Company: LICN
Filing Date: 2025-03-20
Form Type: 6-K
Source: 0001213900-25-025586
Chunk: 0

Company: Lichen International Ltd
Filing Date: 2025-03-20
Form: 6-K
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month ended March 2025

Commission File No. 001-41493

Lichen INTERNATIONAL Ltd

(Translation of registrant’s name into English)

15th Floor, Xingang Square, Hubin North Road,

Siming District, Xiamen City,

Fujian Province, China, 361013

(Address of principal executive office)</div>

Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F

<div align='center'>Form 20-F ☒ Form
40-F ☐</div>

As previously disclosed, on January 23, 2025,
Lichen International Limited (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”)
of The Nasdaq Stock Market LLC (“Nasdaq”), indicating non-compliance with the minimum bid price requirement under Nasdaq Listing
Rule 5450(a)(1) (the “Bid Price Rule”) for continued listing on Nasdaq. The Company was provided 180 calendar days, or until
July 22, 2025, to regain compliance with this rule.

On February 12, 2025, the Company announced that
it received a letter from Nasdaq. This letter stated that, because the Company’s securities had a closing bid price of $0.10 or
less for ten consecutive trading days as of the letter date, unless the Company timely requested a hearing before a Hearings Panel (the
“Panel”) to appeal Nasdaq’s delisting determination, trading of the Company’s securities will be suspended at
the opening of business on February 21, 2025, and a Form 25-NSE will be filed with the U.S. Securities and Exchange Commission to remove
the Company’s securities from listing and registration on Nasdaq, according to Listing Rule 5810(c)(3)(A)(iii).

The delisting determination ended the aforementioned
compliance period before its expiration because the Company’s stock prices have triggered the Low Priced Stocks Rule. The Company
was provided until February 19, 2025 to request an appeal